N-Side

N-Side

Homepage - Power your business with advanced analytics | N-SIDE. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$55m (Public information from Jan 2024)
Company register number 0472.607.061
Ottignies-Louvain-la-Neuve Walloon Brabant (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR201820192020202120222023
Revenues-8.1m12.3m14.4m18.2m23.7m
% growth--52 %17 %27 %30 %
EBITDA1.3m3.3m4.4m3.7m2.2m-
% EBITDA margin-41 %35 %26 %12 %-
Profit<1m<1m2.0m<1m(2.4m)<1m
% profit margin-12 %16 %2 %(13 %)4 %
  • Edit
DateInvestorsAmountRound

€10.0m

Angel
*

€2.7m

Valuation: €50.0m

Late VC
*

€3.2m

Debt
Total Funding$14.0m

Recent News about N-Side

Edit
More about N-Sideinfo icon
Edit

N-SIDE is a technology company specializing in advanced software solutions for clinical supply chain management. Operating in the life sciences sector, N-SIDE serves pharmaceutical companies and clinical research organizations by providing tools that optimize clinical supply planning and risk management. Their software ensures that medications are delivered on time, regardless of trial complexity, by offering unprecedented visibility, control, and reliability. The company leverages advanced analytics and machine learning to forecast and optimize clinical trials, thereby reducing risks and accelerating time-to-market for critical medications. N-SIDE's business model revolves around selling software licenses and providing consulting services to its clients. The company generates revenue through subscription fees and professional services.

Keywords: clinical supply planning, risk management, life sciences, pharmaceutical, advanced analytics, machine learning, software solutions, clinical trials, supply chain, optimization.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.